Novo Nordisk (NVO 4.02%) has found phenomenal success in treating patients with obesity and diabetes.
*Stock prices used were the afternoon prices of Jan. 1, 2025. The video was published on Jan. 3, 2025.

Novo Nordisk (NVO 4.02%) has found phenomenal success in treating patients with obesity and diabetes.
*Stock prices used were the afternoon prices of Jan. 1, 2025. The video was published on Jan. 3, 2025.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.